Evercore Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Evercore Wealth Management's DGX Position: Q2 2026 in Review
Evercore Wealth Management reduced its Quest Diagnostics (DGX) stake by 44% in Q2 2026, selling an estimated $154K and leaving 1,000 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #393.
Evercore Wealth Management first reported a position in DGX in Q2 2014 and has held it in 27 quarters since. The position peaked at $350K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Evercore Wealth Management held 1,000 shares of Quest Diagnostics worth $212K as of Q2 2026.
- Evercore Wealth Management sold 786 Quest Diagnostics shares in Q2 2026, an estimated $154K.
- Quest Diagnostics made up ﹤0.01% of Evercore Wealth Management's portfolio in Q2 2026, its #393 holding.
- Evercore Wealth Management first reported a position in Quest Diagnostics in Q2 2014 and has held it in 27 quarters since.
- Evercore Wealth Management's Quest Diagnostics position peaked at $350K in Q1 2026.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.